T2 Biosystems, Inc.·4

Jan 5, 3:08 PM ET

Elsbree David B 4

4 · T2 Biosystems, Inc. · Filed Jan 5, 2021

Insider Transaction Report

Form 4
Period: 2021-01-01
Transactions
  • Exercise/Conversion

    Common Stock

    2021-01-01+34,188125,269 total
  • Exercise/Conversion

    Restricted Stock Units

    2021-01-01+34,18834,188 total
    Common Stock (34,188 underlying)
  • Award

    Restricted Stock Units

    2021-01-01+32,25832,258 total
    Common Stock (32,258 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    10,000
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F3]The restricted stock units were granted in accordance with the Issuer's Non-Employee Director Compensation Plan and vest on January 1, 2022.
  • [F4]On January 1, 2020 the reporting person was granted 34,188 restricted stock units that vested on January 1, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION